Amazon's massive restructuring is just the beginning as more corporations seek to streamline operations and reduce costs through automation technologies.
These companies provide the critical automation tools and consulting services that enterprises need to modernise their operations and stay competitive.
Each stock was carefully chosen by analysts for direct exposure to the corporate efficiency trend, representing leaders in business process automation sectors.
Total market capitalisation is $421.19B, anchored by a few large-cap positions that dominate the weighting. This concentration suggests a relatively stable profile with generally lower idiosyncratic volatility versus small-cap‑heavy baskets.
NOW: $134.50B
PATH: $8.10B
ADP: $105.10B
Amazon's major restructuring signals a broader corporate shift towards operational efficiency and reduced bureaucracy. This trend creates sustained demand for automation and streamlining solutions as enterprises seek competitive advantages through lean operations and productivity improvements.
This collection focuses on companies providing essential business efficiency tools including workflow automation software, IT consulting, and HR technology. These firms help organisations automate processes and optimise resource allocation during corporate overhauls.
Each company was handpicked by professional analysts for their direct exposure to the corporate efficiency trend. They represent key players in business process automation and operational consulting sectors positioned to benefit as more enterprises prioritise streamlined operations.
Amazon is undertaking its largest corporate layoff in decades, driven by a strategic push to increase efficiency and reduce bureaucracy. This corporate overhaul spotlights an investment opportunity in companies that provide automation and operational streamlining solutions.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Published on January 23
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+4
Here are a few of the assets in this group. Create an account to unlock the full list.
On average, analysts expect assets in this group to grow 134.51% over the next year.
10 of 14 assets in this group are rated Buy by professional analysts.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+134.51%
